Literature DB >> 29206483

Positron emission tomography in Parkinson's disease: insights into impulsivity.

Adam J Stark1, Daniel O Claassen1.   

Abstract

This study reviews previous studies that employ positron emission tomography (PET) imaging assessments in Parkinson's disease (PD) patients with and without Impulsive Compulsive Behaviours (ICB). This begins with a summary of the potential benefits and limitations of commonly utilized ligands, specifically D2/3 receptor and dopamine transporter ligands. Since previous findings emphasize the role of the ventral striatum in the manifestation of ICBs, this study attempts to relate these imaging findings to changes in behaviour, especially emphasizing work performed in substance abuse and addiction. Next, it reviews how increasing disease duration in PD can influence dopamine receptor expression, with an emphasis on differential striatal and extra-striatal changes that occur along the course of PD. Finally, it focuses on how extra-striatal changes, particularly in the orbitofrontal cortex, amygdala, and anterior cingulate, may influence the proficiency of behavioural regulation in PD. The discussion emphasizes the interaction of disease and medication effects on network-wide changes that occur in PD, and how these changes may result in behavioural dysregulation.

Entities:  

Keywords:  PET imaging; Parkinson’s disease; dopamine receptors; impulse control; ventral striatum

Mesh:

Substances:

Year:  2017        PMID: 29206483      PMCID: PMC6410706          DOI: 10.1080/09540261.2017.1398139

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  67 in total

1.  Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.

Authors:  H Olsson; C Halldin; C G Swahn; L Farde
Journal:  J Cereb Blood Flow Metab       Date:  1999-10       Impact factor: 6.200

2.  Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins.

Authors:  K M Kim; K J Valenzano; S R Robinson; W D Yao; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  2001-07-25       Impact factor: 5.157

3.  Overexpression of dopamine D2 receptors reduces alcohol self-administration.

Authors:  P K Thanos; N D Volkow; P Freimuth; H Umegaki; H Ikari; G Roth; D K Ingram; R Hitzemann
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

4.  Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.

Authors:  M Guttman; D Stewart; D Hussey; A Wilson; S Houle; S Kish
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

5.  Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats.

Authors:  M D Lindner; C K Cain; M A Plone; B R Frydel; T J Blaney; D F Emerich; M R Hoane
Journal:  Behav Brain Res       Date:  1999-07       Impact factor: 3.332

6.  Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.

Authors:  J Mukherjee; Z Y Yang; T Brown; R Lew; M Wernick; X Ouyang; N Yasillo; C T Chen; R Mintzer; M Cooper
Journal:  Nucl Med Biol       Date:  1999-07       Impact factor: 2.408

7.  Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.

Authors: 
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

8.  Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.

Authors:  V Kaasinen; K Någren; J Hietala; V Oikonen; H Vilkman; L Farde; C Halldin; J O Rinne
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

9.  Extrastriatal dopamine D(2) receptors in Parkinson's disease: a longitudinal study.

Authors:  V Kaasinen; S Aalto; K NAgren; J Hietala; P Sonninen; J O Rinne
Journal:  J Neural Transm (Vienna)       Date:  2003-06       Impact factor: 3.575

10.  Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.

Authors:  J Hirvonen; S Aalto; V Lumme; K Någren; J Kajander; H Vilkman; N Hagelberg; V Oikonen; J Hietala
Journal:  Nucl Med Commun       Date:  2003-12       Impact factor: 1.690

View more
  1 in total

1.  Self-reported rates of impulsivity in Parkinson's Disease.

Authors:  Megan A Aumann; Adam J Stark; Shelby B Hughes; Ya-Chen Lin; Hakmook Kang; Elise Bradley; David H Zald; Daniel O Claassen
Journal:  Ann Clin Transl Neurol       Date:  2020-03-29       Impact factor: 4.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.